Schedule 13G ownership disclosure
C4 Therapeutics Inc
Security class unavailable · CUSIP: 12529R107
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,134,396
- Percent of class
- 6.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-001611
- Form type
- SC 13G
- Filer
- C4 Therapeutics, Inc.
- CIK
- CIK 1662579
- Filed
- Feb 14, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership